Please assess the completion status of the following clinical trial:

Trial Title: Growth and Tolerance Trial on Infant Formula With HMO

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Gestational age ≥ 37 weeks~* Birth weight ≥ 2500 grams~* No recognized diseases (such as cardiac, pulmonary, gastrointestinal, renal or genetic diseases)~* Boys and girls~* Recruited \< 1 month/age~* Being available for follow up until the age of 4 months~* Exclusive formula feeding or exclusive breast feeding at time of recruitment~Exclusion Criteria:~* Gestational age \<37 weeks~* Birth weight \<2500 grams~* Severe acquired or congenital diseases, mental or physical disorders~* Illness at screening/ inclusion~* Incapability of parents/caregivers to comply with the study protocol~* Received antibiotics within the first month of life~* Not tolerating standard cow's milk based infant formula~* Participation in another clinical trial~* Maternal illicit drug use during pregnancy or post-partum period~* Parent/caregiver does not have a cell phone to use for filling out questionnaires

- Gender: ALL
- Minimum Age: None
- Maximum Age: 1 Month
- Healthy Volunteers: t

Study Arms:
- Breastfed group (Type: NO_INTERVENTION): Non-randomized breastfed reference group
- Control formula (Type: PLACEBO_COMPARATOR): Group receiving standard infant formula
- Formula with HMO (Type: ACTIVE_COMPARATOR): Group receiving standard infant formula supplemented with HMO

Based on this trial design, predict the completion outcome and termination type (if applicable).